Table 4 Survival analysis. Proportional hazards model containing FVC, age and gender as covariates
From: Pirfenidone improves survival in IPF: results from a real-life study
| HR | 95% CI | P value | |
|---|---|---|---|
| Centre | 0.28 | 0.16, 0.48 | P<0.0001 |
| Gender | 1.96 | 1.19, 3.22 | P<0.008 |
| Age | 1.03 | 1.01, 1.05 | P<0.002 |
| FVC | 0.97 | 0.96, 0.98 | P<0.0001 |